CA2060490A1 - Protection from shock subsequent to injury by double-stranded rnas - Google Patents
Protection from shock subsequent to injury by double-stranded rnasInfo
- Publication number
- CA2060490A1 CA2060490A1 CA002060490A CA2060490A CA2060490A1 CA 2060490 A1 CA2060490 A1 CA 2060490A1 CA 002060490 A CA002060490 A CA 002060490A CA 2060490 A CA2060490 A CA 2060490A CA 2060490 A1 CA2060490 A1 CA 2060490A1
- Authority
- CA
- Canada
- Prior art keywords
- injury
- double
- protection
- stranded rnas
- dsrna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention details the use of double stranded RNA (dsRNA) for reactivation of natural defense systems within human cells, tissues and organs reduced to inadequate function subsequent to injury. Specific treatments for acquired immune deficient states are described. dsRNA stimulates the release of an immune lymphokine, tumor necrosis factor (TNF) and protects against the toxic effects associated with increased TNF levels.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002060490A CA2060490C (en) | 1992-01-31 | 1992-01-31 | Protection from shock subsequent to injury by double-stranded rnas |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002060490A CA2060490C (en) | 1992-01-31 | 1992-01-31 | Protection from shock subsequent to injury by double-stranded rnas |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2060490A1 true CA2060490A1 (en) | 1993-08-01 |
CA2060490C CA2060490C (en) | 2002-07-30 |
Family
ID=4149195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002060490A Expired - Fee Related CA2060490C (en) | 1992-01-31 | 1992-01-31 | Protection from shock subsequent to injury by double-stranded rnas |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2060490C (en) |
-
1992
- 1992-01-31 CA CA002060490A patent/CA2060490C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2060490C (en) | 2002-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2127876A1 (en) | Imidazole derivatives and their use as cytokine inhibitors | |
CA2199117A1 (en) | Compounds and methods for the treatment of cancer | |
CA2028223A1 (en) | Synergistic microbicidal combinations containing 4,5-dichloro-2-octyl-3-isothiazolone and certain commercial biocides | |
BG91270A (en) | ANTIVIRAL AND ANTIBACTERIAL AGENT AND METHOD OF ITS USE | |
CA2257077A1 (en) | Treatment of diarrhea | |
EP0666923A4 (en) | Targeted delivery of poly- or oligonucleotides to cells. | |
CA2291065A1 (en) | Raf kinase inhibitors | |
EP0933995B8 (en) | Method of treating endothelial injury | |
EP2591793A3 (en) | Treatment of autoimmune disease | |
WO1998019167A3 (en) | Cell stress regulated human mhc class i gene | |
CA2103458A1 (en) | Method and composition to reduce myocardial reperfusion injury | |
AU6751294A (en) | Protection from shock subsequent to injury by double-standard RNAs | |
EP1157698A3 (en) | Treatment of inflammatory diseases with oxypurine nucleosides | |
AU1618992A (en) | Synergistic interplay of lymphokines and dsrnas | |
WO1999024077A3 (en) | Compositions and methods for targeted delivery of biologically-active factors | |
CA2060490A1 (en) | Protection from shock subsequent to injury by double-stranded rnas | |
CA2086918A1 (en) | Biologically active compounds from blue-green algae | |
RU96124444A (en) | BIOLOGICAL COMPOSITION FOR THE TREATMENT OF THE RAS "COLLAHIT" | |
EP1091757A4 (en) | Alpha emitting constructs and uses thereof | |
SU1727820A1 (en) | Method for stimulation of spermatogenesis in bulls | |
RU97103680A (en) | METHOD FOR TREATMENT TARGET | |
Khan | Effects of gravity separation and seed treatment on seed quality in wheat. | |
RU95111615A (en) | METHOD FOR TREATING AN BODY OR SYSTEM WITH A LOW LEVEL OF RESPONSE RESPONSE TO AN IRRITATIVES WITH A MODERATE OR HIGH LEVEL OF CONGENITAL REACTION OF THE ORGANISM IN GENERAL | |
Wojciechowska et al. | Relationship between Rotatoria and nannoplankton in late spring in a mesotrophic lake. | |
TH77751B (en) | Preventive and / or therapeutic agents for infectious diseases of fish and / or shellfish. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |